Peak Resources-Shelby: Drug Storage Violations - NC
The resident, identified in inspection records only as Resident #75, was admitted to the facility with type 2 diabetes. In late November 2025, her physician assistant ordered semaglutide, a drug used to regulate blood sugar and support weight loss, to be injected once a week every Monday. The pharmacy received the order on November 25.
But the order that went to the pharmacy was missing the dosage. The pharmacist, reached by phone during the inspection, said the facility eventually sent a corrected order, and the medication was delivered sometime after that. In the meantime, three Mondays passed.
On December 1, Nurse #2 charted that she had administered the injection at 8:00 AM. She had not. On December 8, she charted that the resident refused. The resident had not refused. On December 15, she finally wrote that the medication was unavailable, pending delivery. That part was accurate, but it described all three weeks.
When inspectors interviewed Nurse #2 on February 9, 2026, she confirmed that semaglutide was not available on December 1, December 8, or December 15, and was not administered on any of those dates. She said she had documented the December 1 administration in error and should have written that the medication was unavailable. She said the same about the December 8 refusal notation. She did not explain why she had charted a drug as given when she knew it had not been.
Resident #75 is cognitively intact, according to her quarterly assessment. She told inspectors on February 9 that the medication was not administered until January 2026, roughly six weeks after it was ordered.
The administrator said she had no idea any of this had happened. When inspectors interviewed her on February 11, she said she was unaware that the resident had gone without her medication because it had not been delivered. She acknowledged that when a medication is not given, the record should reflect the accurate reason. Inspectors were unable to reach the former Director of Nursing.
What the MAR showed and what actually happened were two different things for six weeks. A resident's medical record said she received a drug. She did not. It said she refused a drug. She did not. The inaccurate entries sat in her chart, uncorrected, until a federal inspection in February surfaced them.
CMS classified the deficiency at a level of minimal harm or potential for actual harm. The inspection, completed February 11, 2026, identified this as the sole deficiency cited in the health survey.
Semaglutide works cumulatively. The drug is typically started at a low dose and increased over time as the body adjusts. A six-week delay at the outset, before the first dose is ever administered, is six weeks without any of that effect, for a resident whose physician assistant ordered it specifically to help manage her blood sugar.
Resident #75 knew she wasn't getting her injection. She told inspectors exactly when it finally started. The chart, for those six weeks, said otherwise.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Peak Resources- Shelby from 2026-02-11 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 5, 2026 · Our methodology
Peak Resources- Shelby in Grover, NC was cited for violations during a health inspection on February 11, 2026.
The resident, identified in inspection records only as Resident #75, was admitted to the facility with type 2 diabetes.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.